Compare SPEG & HURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | SPEG | HURA |
|---|---|---|
| Founded | 2024 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 158.7M | 160.5M |
| IPO Year | 2025 | 2010 |
| Metric | SPEG | HURA |
|---|---|---|
| Price | $10.43 | $2.01 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $8.04 |
| AVG Volume (30 Days) | 26.4K | ★ 230.8K |
| Earning Date | 01-01-0001 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 47.93 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.98 | $0.41 |
| 52 Week High | $11.03 | $3.43 |
| Indicator | SPEG | HURA |
|---|---|---|
| Relative Strength Index (RSI) | 63.87 | 51.91 |
| Support Level | $10.26 | $1.83 |
| Resistance Level | $11.03 | $2.22 |
| Average True Range (ATR) | 0.01 | 0.13 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 100.00 | 57.14 |
Silver Pegasus Acquisition Corp is a blank check company.
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.